BTIG Issues a Buy Rating on Acutus Medical (AFIB)
TipRanksApr 20, 2023 09:28 ET
BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)
TipRanksMar 22, 2023 16:26 ET
BTIG Sticks to Their Buy Rating for Acutus Medical (AFIB)
TipRanksMar 16, 2023 21:08 ET
BTIG Remains a Buy on Acutus Medical (AFIB)
TipRanksDec 21, 2022 09:30 ET
BTIG Keeps Their Buy Rating on Acutus Medical (AFIB)
TipRanksNov 10, 2022 22:20 ET
BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)
TipRanksNov 3, 2022 09:25 ET
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Acutus Medical (AFIB)
TipRanksSep 28, 2022 06:10 ET
Acutus Medical Is Maintained at Neutral by Goldman Sachs
Dow JonesAug 16, 2022 08:35 ET
Acutus Medical Price Target Raised to $1.50/Share From $1.00 by Goldman Sachs
Dow JonesAug 16, 2022 08:35 ET
Acutus Medical Analyst Ratings
Benzinga Analyst RatingsAug 16, 2022 08:26 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Acutus Medical (AFIB)
TipRanksAug 11, 2022 22:35 ET
Acutus Medical (AFIB) Gets a Buy Rating from BTIG
TipRanksJul 22, 2022 05:25 ET
Acutus Medical (AFIB) Gets a Buy Rating from BTIG
TipRanksJul 1, 2022 09:22 ET
Acutus Medical Is Maintained at Buy by BTIG
Dow JonesJun 24, 2022 09:29 ET
Acutus Medical Price Target Cut to $1.50/Share From $2.00 by BTIG
Dow JonesJun 24, 2022 09:29 ET
Acutus Medical analyst ratings
Benzinga Analyst RatingsJun 24, 2022 09:20 ET
BTIG Maintains Buy on Acutus Medical, Lowers Price Target to $1.5
Benzinga Real-time NewsJun 24, 2022 09:20 ET
BTIG Adjusts Acutus Medical's Price Target to $1.50 From $2, Reiterates Buy Rating
MT NewswiresJun 24, 2022 09:08 ET
No Data
No Data